chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt recvd a series of 3 injects of Engerix-B & 3rd & final inject was given DEC90; testing indicated that pt had seroconverted 5NOV91 suffered a needlestick; pt was HBSAG neg; f/u testing of the pt indicated that pt anti HBS neg;
I don't have smell; stiff neck; little cough; cold like symptoms; sore throat; I don't have smell or taste; injection arm bothered little bit; This spontaneous case was reported by a patient and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff neck), COUGH (little cough), NASOPHARYNGITIS (cold like symptoms), OROPHARYNGEAL PAIN (sore throat) and AGEUSIA (I don't have smell or taste) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), OMEPRAZOLE, ALENDRONATE SODIUM (FOSAMAX), COLECALCIFEROL (VITAMIN D3) and CELECOXIB for an unknown indication.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff neck), COUGH (little cough), NASOPHARYNGITIS (cold like symptoms), OROPHARYNGEAL PAIN (sore throat), AGEUSIA (I don't have smell or taste) and PAIN IN EXTREMITY (injection arm bothered little bit). On an unknown date, the patient experienced ANOSMIA (I don't have smell). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 14-May-2021, PAIN IN EXTREMITY (injection arm bothered little bit) outcome was unknown. At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff neck), COUGH (little cough), NASOPHARYNGITIS (cold like symptoms), OROPHARYNGEAL PAIN (sore throat), AGEUSIA (I don't have smell or taste) and ANOSMIA (I don't have smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The action taken with the drug was not applicable.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 64-year-old male patient received BNT162b2 (BNT162B2), on 19Mar2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 64 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing), notes: other medical history:HTN. The patient's concomitant medications were not reported. Past drug history included: Known allergies: aspirin, reaction(s): "Known allergies: aspirin", notes: Known allergies: aspirin. The following information was reported: COVID-19 (medically significant) with onset 2022, outcome "not recovered", DRUG INEFFECTIVE (medically significant) with onset 2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09May2022) Negative; (10May2022) Negative; (13May2022) Positive. Therapeutic measures were taken as a result of covid-19, drug ineffective.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provide and plausible temporal association, the causality between BNT162B2 and events cannot be completely excluded.
rash on different areas of the body - chest and face; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on different areas of the body - chest and face) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash on different areas of the body - chest and face). At the time of the report, RASH (rash on different areas of the body - chest and face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided No treatment medications were provided
Received second dose of vaccine at 1730 on 2/12/2021.  He started with hives on 2/14/2021 and reported to Urgent Care for evaluation.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient had a medical history of allergy/reaction to sympathomimetics (unspecified). On 04-JAn-2013 the patient was vaccinated subcutaneously with the first dose of ZOSTAVAX, lot number H018092, expiration date: 04-JAN-2014, dose: 0.65 ml. On 08-AUG-2013 the patient was vaccinated subcutaneously with the second dose of ZOSTAVAX, lot number; J001010, expiration date 24-APR-2014, dose: 0.65ml. Concomitant medications included: pravastatin, potassium (manufacturer unknown), omeprazole (manufacturer unknown), hydrochlorothiazide (also reported as hctz) and COSOPT. The pharmacist reported that after receiving the second dose of ZOSTAVAX, in approximately August 2013 the patient hadn't been feeling well (specific symptoms unspecified). The patient sought medical attention and she called to the pharmacy. The patient's outcome ws not reported. The relatedness between the adverse event and the vaccination with ZOSTAVAX was not provided. Additional information has been requested.
soreness at injection sites; light neck pain several hours after injection; This is a spontaneous report from a contactable consumer. A 56-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 22Jan2021 12:00 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a workplace clinic. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. On 22Jan2021 14:00, the patient experienced soreness at injection sites and light neck pain several hours after injection. No treatment was received for the adverse events. Clinical outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Previously received Moderna vaccine on 3/16/21 and 4/13/21. This was the first Pfizer vaccine that I received.   Received vaccine at 10am on 1/17/22. Around noon on 1/18/22, noticed tightness in chest. Checked heart rate and resting heart rate wouldn't go below 110 (normally in the 70s for me). Continued like this until roughly 8pm, where it stayed in the 80s throughout the night. Also during the night I noticed armpit pain and woke up 1/19/22 to swelling of my right armpit. As of 5pm, the pain is nearly gone but the swelling has remained.  While I actually felt better with this vaccine than with my last Moderna vaccine, these symptoms were new to me.
Wait a long time after getting the first dose to get the second one; Extreme pain under her arm pit in lymph nodes in left arm, and really painful; Extreme pain under her arm pit in lymph nodes in left arm, and really painful; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Extreme pain under her arm pit in lymph nodes in left arm, and really painful), LYMPH NODE PAIN (Extreme pain under her arm pit in lymph nodes in left arm, and really painful) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Wait a long time after getting the first dose to get the second one) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 00321-2A and 004D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Wait a long time after getting the first dose to get the second one). In January 2022, the patient experienced AXILLARY PAIN (Extreme pain under her arm pit in lymph nodes in left arm, and really painful) and LYMPH NODE PAIN (Extreme pain under her arm pit in lymph nodes in left arm, and really painful). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 13-Jan-2022, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Wait a long time after getting the first dose to get the second one) had resolved. At the time of the report, AXILLARY PAIN (Extreme pain under her arm pit in lymph nodes in left arm, and really painful) and LYMPH NODE PAIN (Extreme pain under her arm pit in lymph nodes in left arm, and really painful) outcome was unknown.            No Concomitant product use was reported.  The patient received the first dose of the Moderna vaccine on 17-Jul-2021 and second vaccine on 13-Jan-2022. The patient mentioned that they did waited a long time after getting the first dose to get the second one and reported that after the second dose, the patient was experiencing extreme pain under their arm pit in lymph nodes in left arm, and really painful. The patient was taking Tylenol which helped a little and ibuprofen. The patient reported not being on any concomitant medications for any other health conditions. Reportedly, the patient stated that if they feel like it was not getting better, then the patient would reach out to their doctor.
Initial report received on 21 August 2008 from a health care professional. A 2 months old male patient received on 19 June 2008 at 11:30 hours the following vaccinations: DAPTACEL (lot #C2797AA), intramuscular first dose into the left thigh; IPOL (lot # C2797AA), into the left thigh; ACTHIB (sanofi pastiru ltd. lot # lot # UF370AA which corresponds to sanofi pastiru SA lot # A0824-2) intramuscular first dose into the right thigh and PREVNAR (lot # C63110), intramuscular first dose into the right thigh. Approximately 4.5 hours later the same day (at 16:50 hours) the patient began crying for approximately 4 hours. The patient was slightly consolidate when legs held in curtain way. Denied fever. TYLENOL was given as treatment at 19:30 hours. The patient fell asleep by 20:30 hours with no further crying. The patient recovered. The patient had no relevant medical history and no allergies.
No additional AEs reported.; administration of improperly stored STERILE DILUENT vials to reconstitute MMR II.; This spontaneous report was received from a nurse (also reported as medical assistant) referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.       On an unknown date, sterile diluent experienced temperature excursion with -20.4 Celsius degrees for 109 hours.   On 17-SEP-2022, the patient received the improperly stored sterile diluent vials (0.7 mL, lot # U034540, expiration date: 15-MAY-2024; strength, dose, frequency and route of administration were not reported) to reconstitute measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection (strength, dose, route of administration, anatomical location, lot# and expiration date were not reported) for prophylaxis (product storage error). No additional adverse events (AEs) or product quality complaints (PQCs) were reported.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included ATENOLOL and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant products included medications for hormone replacement therapy. Treatment information was not provided.
Redness on her arm near the injection site; This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a 74-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced erythema of extremities. On an unknown date, the outcome of the erythema of extremities was recovered/resolved.   It was unknown if the reporter considered the erythema of extremities to be related to Influenza vaccine Quadrivalent unspecified season.  Additional information received were as follows: The age at vaccination was not reported. The patient experienced redness on her arm near the injection site. This case is linked to the case US2019158360, reported by the same reporter.
EXPERIENCED UNUSUAL TWINGE/PAIN IN RIGHT TMJ.  I WAS NOT CHEWING, TALKING OR YAWNING.  NO HISTORY OF TMJ PROBLEMS. PAIN /DISCOMFORT IN JOINT NOTED WHEN EATING AND OPENING WIDE.  CONTINUED FOR SEVERAL DAYS. I AM REPORTING THIS BECAUSE MY COLLEAGUE WHO HAD RECEIVED HER FIRST MODERNA DOSE 3 WEEKS PRIOR TO MY EVENT HAD EXPERIENCED A PARTIAL JAW DISLOCATION WHEN SHE WAS NOT EATING, TALKING OR YAWNING.  SHE TOO HAS NO HISTORY OF TMJ  PROBLEMS.  HER JAW PAIN CONTINUES.
terribly sick; This case was reported by a consumer and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as the case was reported by the patient. The age at vaccination was not reported. The patient got terribly sick after the second dose of Shingles vaccine.
Required colon surgery after 1st dose of Shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of lower gastrointestinal disorder in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced lower gastrointestinal disorder. On an unknown date, the outcome of the lower gastrointestinal disorder was unknown.   It was unknown if the reporter considered the lower gastrointestinal disorder to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. It was reported that, the patient required colon surgery after receiving Shingrix. The reporter did not consent to follow-up.
got chickenpox MAY98 had vax AUG97;got 30 pox not very ill recovered quickly;
It was like a very bad cold with a fever, but never got to 100. I had body aches, pains, coughing, head congestion, running nose, fatigue, very sore throat, and back of my eyes was hot. I tested positive for COVID-19. My symptoms morphed into something different but I don't really remember my symptoms. I talked to the nurse after being sick for 6 days. She asked me if I wanted PAXLOVID and I decided not to take it because I didn't think my symptoms were hitting me that bad. I still have congestion and fatigue.
Patient was given 0.5ml of Influenza vaccine, IM @ 1405 in L deltoid. Patient was starting to leave clinic and said she felt "lightheaded and dizzy", @ 1406 we had patient lay down and monitor BP x 20 minutes.
Patient's first Covid vaccine was Pfizer. Received Moderna as her second dose instead of Pfizer
shingles broke out on me; This is a spontaneous report received from a contactable consumer. This consumer (patient) reported that a 63-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 06Apr2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient said shingles broke out on her. Outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recv vax & devel an allergic rxn characterized by hives & airway occlusion;went to ER where recv a steroid inj & oral DPH;pt recovered;c/o sensation of swelling of throat;c/o redness & funny feeling in throat;MD noted raised area;
arm was sore; This is a spontaneous report from a non-contactable other healthcare professional. A adult female patient received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date patient experienced arm was sore. The outcome for the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
In the middle of the night I woke up to sharp stomach pain and broke out in night sweats. Started in my upper rib cage area, then traveled down to abdominal area. I had arm pain and a headache with sensitivity to light. I started to vomit and have diarrhea. Felt burning pain, and went to the doctor later that day. The doctor stated that I would need to wait it out and drink lots of fluids. Event lasted about 6 hours.
I started becoming short of breath at times. Went to doctor and had a chest X-ray and it was clear. Hadn't gotten better and started having a nasty cough with a bad taste in my mouth. Went to my doctor again and was told I have Bronchitis. Was given an Benzonatate Cough Syrup and an Albuterol Inhaler. Still have a mild cough and am going back to my doctor in 2 weeks.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2011, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, dose number, route, anatomical site of vaccination, lot number and expiration date were not provided) as prescribed and/or administered by a pharmacist at a pharmacy for the long-term prevention of shingles and zoster-related conditions. On an unknown date, subsequent to zoster vaccine live (ZOSTAVAX) inoculation, the patient was treated by a physician for shingles (herpes zoster).  As a direct and proximate result of the used of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of herpes zoster was not recovered.  The reporter assessed that the event was related to zoster vaccine live (ZOSTAVAX).
Vertigo in the middle of the night andthe next morning.; Then dizzy and just off for a few more hours.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 10:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included history of blood clots. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ASPIRIN for the indication blood clot and its ongoing. Concomitant medications also included VITAMIN C, GLUCOSAMINE, ZINC, and MAGNESIUM, all for an unknown indication from an unknown dates and unknown if ongoing. On 27Mar2021 at 03:00, the patient experienced vertigo in the middle of the night and the next morning. Then on the same day dizzy and just off for a few more hours. The events did not result in doctor or other health care professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizzy and vertigo were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
It was reported that a 54 year old female pt received a Fluzone UNSP '99-'00 vaccination on 10/15/99. Reportedly, within 2 hours, post vax, the pt experienced headache, achiness, fatigue and nausea. Placed on Phenergan for nausea. Pt was out of work and in bed. One week later, still feeling nausea, lightheaded and loss of appetite. Also experienced flushing across chest and up neck. Pt is on Premarin from hysterectomy but has not had this flushing before. (**A lot number was provided (4928136415) was determined to be an Aventis Pasteur, Inc. Fluzone product code.)
Body aches; cold; cough; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PAIN (Body aches), NASOPHARYNGITIS (cold) and COUGH (cough) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced CHILLS (chills), PAIN (Body aches), NASOPHARYNGITIS (cold) and COUGH (cough). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. At the time of the report, CHILLS (chills), PAIN (Body aches), NASOPHARYNGITIS (cold) and COUGH (cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by reporter. Treatment medication not reported.
Redness, swelling 50mm to (R) arm injection site, itching. Using HC 1% cream and warm compresses. Afebrile.
Child was irritable, loss of appetite, tired x5d, no tx given.  Eating well, no s/s dehydration.  Condition improved starting today 3/12/2010.